{
    "clinical_study": {
        "@rank": "132952", 
        "acronym": "CHEXU 01", 
        "arm_group": {
            "arm_group_label": "Fast Gelling Dressing", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this post market clinical follow-up (PMCF) investigation is to\n      evaluate performance and safety of fast gelling dressing when used as intended in Diabetic\n      Foot Ulcer (DFU).\n\n      The primary endpoint will be Changes from baseline in the condition of the peri-wound skin\n      measured by the following variables; maceration, redness/irritation, rash/eczema,\n      blistering, dermatitis, skin stripping, trauma to wound edges and product degradation on the\n      skin"
        }, 
        "brief_title": "Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended.", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetic Foot Ulcers", 
        "condition_browse": {
            "mesh_term": [
                "Ulcer", 
                "Foot Ulcer", 
                "Diabetic Foot"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Both gender \u226518 years old.\n\n          2. Subjects with type 1 or 2 diabetes mellitus.\n\n          3. Texas Grade A1 or 2, C1 or 2\n\n          4. Exuding diabetic foot ulcer\n\n          5. Ulcer localisation; below the ankle\n\n          6. Signed Informed Consent.\n\n        Exclusion Criteria:\n\n          1. Known allergy/hypersensitivity to the dressing.\n\n          2. HbA1c \u2265 10% (86 mmol/mol) (most recent value within 3 months)\n\n          3. Wound infection requiring systemic treatment\n\n          4. Subjects who will have problems following the protocol.\n\n          5. Subjects included in other ongoing clinical investigation at present or during the\n             past 30 days.\n\n          6. Toe pressure less than 70 mmHg\n\n          7. Clinical suspicion of osteomyelitis (based on probe to bone/radiological changes)\n\n          8. Dry wounds"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02091778", 
            "org_study_id": "CHEXU 01"
        }, 
        "intervention": {
            "arm_group_label": "Fast Gelling Dressing", 
            "intervention_name": "Fast gelling dressing", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 19, 2014", 
        "number_of_arms": "1", 
        "official_title": "Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended.", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measured by the following variables; maceration, redness/irritation, rash/eczema, blistering, dermatitis, skin stripping, trauma to wound edges and product degradation on the skin", 
            "measure": "change in peri-wound skin", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02091778"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Molnlycke Health Care AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Molnlycke Health Care AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}